Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 with Oxaliplatin in Adjuvant Gastric Cancer
NCT02191566Phase 2Terminated
- Sponsor
- Kangbuk Samsung Hospital
- Start
- May 2015
- Primary completion
- Oct 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in gastric cancer (GC), sponsored by Kangbuk Samsung Hospital. Started May 2015; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02191566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191566.